Mesothelioma Doctors

Dr. Nader
Tulsa, OK

Dr. Daniel Nader

Director, Lung Center

CTCA Southwestern Regional Medical Center

10109 E. 79th Street (81st Street & Highway 169)
Tulsa, OK 74133
(918) 286-5000

University of Health Sciences - 1977

Naval Regional Medical Center

Naval Regional Medical Center

Overview

Based in Tulsa, the second largest city in Oklahoma, is Dr. Daniel Nader, a successful pulmonologist with decades of experience fighting diseases of the chest and respiratory tract. He currently works with Cancer Treatment Centers of America (CTCA), where he directs the Lung Center and serves as vice chief of staff at CTCA’s Southwestern Regional Medical Center. Dr. Nader has been part of CTCA since 1992, two years after the facility opened its doors.

Educational Background

Dr. Nader received his medical degree from the University of Health Sciences in Kansas City, Missouri. He went on specialize in pulmonary medicine at the Naval Regional Medical Center in San Diego, California, where he completed both a residency and fellowship. He is board certified in internal medicine, pulmonary disease and critical care medicine.

Professional Highlights

Dr. Nader is a known leader in the treatment of pulmonary diseases in the “Sooner State.” As Oklahoma’s representative to the American College of Chest Physicians, he has served in a critical role that involved not only sharing his vast knowledge of pulmonary diseases, but also serving as a patient advocate and lobbying for assistance from government officials. Dr. Nader’s efforts have been rewarded with a seat on the board of directors of the American Association for Bronchology.

For more than two decades, Dr. Nader has helped patients and developed innovative treatments for lung and chest diseases at the Cancer Treatment Centers of America, the only hospital in Oklahoma dedicated exclusively to cancer treatment. His areas of expertise include lung cancer, mesothelioma, and tumors of the bronchus, one of two air tubes that connect the windpipe, also known as the trachea, and the lungs. By combining two treatments – high-dose rate brachytherapy and intratumoral chemotherapy – Dr. Nader has pioneered a new treatment for the fight against bronchial tumors.

Before joining CTCA, Dr. Nader served as medical director of a pulmonary function lab and respiratory therapy department. Since 2006, he has also led CTCA’s national efforts in pulmonary and critical care, helping the organization’s various cancer centers work together toward a common goal.

Close collaboration between doctors is one of CTCA’s major strengths, Dr. Nader says. “At this center, all under one roof, are all the specialties that are needed to care for that particular patient,” he says. “We meet on a regular basis to discuss our complex patients, discuss what additional therapies might be a benefit that maybe we haven’t thought of on our own. … It allows us to come up with the most comprehensive regimen that’s going to be best for that particular patient.”